peji_banner

nhau

Epiprobe's pan-cancer biomarker yakatevera Siemens Healthcare's "Angel Project" muWuwei.

Iyo "Angel Project" inobatsira kunyatsogadzirisa urombo hwekurapa.

Musi waKukadzi 19, 2023, Central Committee yeChinese People's Political Consultative Conference (CPPCC) neSiemens vakabatana vakatanga chirongwa cheGuardian Angel Project muGansu Province, vachipa michina yemhando yepamusoro uye nekupa zviridzwa zvemhando yepamusoro zvekurapa kunzvimbo yeko.Iyo purojekiti yakaita basa rakakosha mukuzadza nemazvo maburi mumidziyo yekuongorora uye yekurapa uye tekinoroji padanho repasi redunhu-level zvipatara, kuvandudza kuongororwa uye kurapwa kwezvipatara zvekutanga, kuderedza kunetsa mukutsvagira veruzhinji kurapwa. .

Makirasi ekudzidzira zvekurapa akavhurwa nechinangwa chekuwedzera kuvandudza timu yezvekurapa uye nhanho yavo yehunyanzvi, pamwe nekusimudzira kugona kwevashandi vekurapa kurapa nekuponesa hupenyu.Mudanho rinotevera, nhevedzano yezvirongwa zvekudzidzisa kusimudzira manejimendi ekurapa uye kuongororwa uye kugona kurapwa kuchaitwa mudunhu rese.Epiprobe yakatevera iyo "Angel Project" muWuwei, ichipa tekinoroji nyowani yekuonekwa kwegomarara ine yakazara cancer mamaki kushandira vanhu veko uye kubatsira mukusimudzira indasitiri yekurapa nehutano.

Epiprobe yakatevera iyo "Angel Project" muWuwei.

Wuwei iri pakati pedunhu reGansu kuchamhembe kwakadziva kumadokero kweChina uye ine nhoroondo refu.Inozivikanwa seguta renhoroondo yenyika uye tsika.Zvisinei, pasinei nenhoroondo yaro yakapfuma, nhanho yekurapa munzvimbo iyi yakarembera.Kuti vavandudze maitiro ezvekurapa munharaunda uye kuchengetedza hutano hwevanhu veko, Epiprobe yakatevera Siemens Medical uye Chinese People's Political Consultative Conference's "Angel Project" muWuwei, ichipa methylation yekuona masevhisi.

Kuti uvandudze chirwere chegomarara chezvipatara muWuwei, Epiprobe yakashanda pamwe chete nezvipatara zvemunharaunda kuti ipe methylation yekuongorora tekinoroji yekudzidziswa, ichipa vanachiremba veko nzira nyowani yekutanga, yakanyatsojeka, uye inobudirira kuongorora cancer.

Pan-cancer marker TAGMe® inoperekedza hutano hwemadzimai emuno.

Chiitiko chegomarara rekubereka mumadzimai chakanyanya.Vanoda kusvika 140 000 vanhu vatsva vegomarara remuchibereko uye zviuru makumi masere zvegomarara reendometrial vanoonekwa gore rega rega, vachiiswa kekutanga nerechipiri zvakateerana mugomarara remuchibereko.Nekuda kwekuganhurirwa munzira dzekuona, nyaya zhinji dzegomarara remuchibereko nereendometrial dzinoonekwa padanho repamusoro.

Zvinoenderana nenhamba dzekutsvagisa, huwandu hwemakore mashanu ekupona kwegomarara repamuromo wechibereko chepamusoro i40% chete.Kana kuongororwa kuchigona kuitwa muchikamu chisati chave negomarara, chiyero chekurapa chinogona kusvika 100%, kunyatsozadzisa chinangwa chekubvisa gomarara rechibereko nekuchengetedza hupenyu hwakawanda.

Kubatsira vakadzi muWuwei kudzivirira nekudzora gomarara rechibereko neendometrial, Epiprobe yakatevera Siemens Healthcare neDemocratic League's “Angel Project” kuWuwei, ichiunza tekinoroji yekuongorora methylation kuchengetedza hutano hwevakadzi veko.

Epiprobe yakagadzira yakasarudzika pan-cancer biomarker, TAGMe, uye Me-qPCR chikuva chisingade kurapwa metabisulfite, kugadzira TAGMe DNA Methylation Detection Kits yekenza yekubereka yevakadzi.Mamiriro ayo akazara ekushandisa anogona kubatsira vakadzi vazhinji kudzivirira kutyisidzira kwegomarara remuchibereko uye endometrial.

Scenario 1: Kuongororwa kwekare kwegomarara (kuonekwa kwekutanga kwe-pre-kenza maronda)

Scenario 2: Yakanyanya-njodzi HPV huwandu hwevanhu triage

Muenzaniso 3: Kuongororwa kwekubatsira kwevanhu vanofungidzira

Chimiro chechina: Kuongororwa kwengozi yezvironda zvakasara mushure mekuvhiyiwa

Chimiro chechishanu: Postoperative yehuwandu hwekudzokorora kutarisa

Epiprobe akazvipira kudanana uye anotevera "Angel Project".Kutanga kubva kuWuwei chiteshi, inoparadzira hutano kune vanhu vazhinji.


Nguva yekutumira: May-04-2023